We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
151
CALL
Charles Schwab
SCHW
$181B
| $5.87M | 0.15% |
90,000
| – | – |
|
152
CALL
Mondelez International
MDLZ
$80.5B
| $5.85M | 0.15% |
100,000
+89,300
| +835% | +$5.04M |
|
153
CALL
Whirlpool
WHR
$2.47B
| $5.73M | 0.14% |
26,000
| – | – |
|
154
CALL
Lowe's Companies
LOW
$118B
| $5.71M | 0.14% |
+30,000
| New | +$5.15M |
|
155
CALL
BioMarin Pharmaceuticals
BMRN
$11.7B
| $5.67M | 0.14% |
75,100
-101,900
| -58% | -$8.32M |
|
156
CALL
Blackrock
BLK
$170B
| $5.66M | 0.14% |
7,500
+6,000
| +400% | +$4.35M |
|
157
PUT
iQIYI
IQ
$1.24B
| $5.65M | 0.14% |
340,000
+220,100
| +184% | +$5.08M |
|
158
CALL
Crown Holdings
CCK
$12.9B
| $5.58M | 0.14% |
57,500
+48,500
| +539% | +$4.67M |
|
159
PUT
DraftKings
DKNG
$11.8B
| $5.52M | 0.14% |
90,000
+40,000
| +80% | +$2.4M |
|
160
CALL
AstraZeneca
AZN
$266B
| $5.47M | 0.14% |
+55,000
| New | +$5.53M |
|
161
CALL
EOG Resources
EOG
$77.5B
| $5.44M | 0.14% |
+75,000
| New | +$4.79M |
|
162
CALL
Rio Tinto
RIO
$158B
| $5.44M | 0.14% |
+70,000
| New | +$5.74M |
|
163
PUT
Diamondback Energy
FANG
$56.2B
| $5.37M | 0.13% |
73,100
-55,100
| -43% | -$3.77M |
|
164
CALL
Norfolk Southern
NSC
$75B
| $5.37M | 0.13% |
20,000
+8,600
| +75% | +$2.18M |
|
165
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.49B
| $5.31M | 0.13% |
80,000
+70,000
| +700% | +$4.37M |
|
166
CALL
S&P Global
SPGI
$122B
| $5.29M | 0.13% |
15,000
| – | – |
|
167
PUT
Costco
COST
$423B
| $5.29M | 0.13% |
15,000
-41,200
| -73% | -$14.3M |
|
168
CALL
Qualcomm
QCOM
$159B
| $5.28M | 0.13% |
+39,800
| New | +$5.74M |
|
169
CALL
XPO
XPO
$23.4B
| $5.26M | 0.13% |
123,463
+65,924
| +115% | +$2.73M |
|
170
CALL
Caesars Entertainment
CZR
$6.03B
| $5.25M | 0.13% |
+60,000
| New | +$5.03M |
|
171
CALL
Marvell Technology
MRVL
$165B
| $5.24M | 0.13% |
107,000
-107,600
| -50% | -$5.27M |
|
172
CALL
Quince Therapeutics
QNCX
$22.5M
| $5.22M | 0.13% |
+725
| New | +$5.22M |
|
173
CALL
Netflix
NFLX
$305B
| $5.22M | 0.13% |
100,000
-20,000
| -17% | -$1.06M |
|
174
CALL
Rekor Systems
REKR
$84.6M
| $5.2M | 0.13% |
+260,000
| New | +$3.87M |
|
175
CALL
Zillow
Z
$7.71B
| $5.19M | 0.13% |
40,000
-212,500
| -84% | -$31.5M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.